Skip to main content
. 2020 Feb 7;10:2086. doi: 10.1038/s41598-020-59089-x

Figure 4.

Figure 4

Analysis of progression-free survival according to extent of resection and use of radiotherapy in each molecular subtype. (a) ODG, (b) IDHmt, (c) IDHwt. *Means statistically significant difference in the two groups. ODG: oligodendroglioma, isocitrate dehydrogenase-mutant and 1p/19q codeleted; IDHmt: diffuse astrocytoma, isocitrate dehydrogenase-mutant; IDHwt: diffuse astrocytoma, isocitrate dehydrogenase-wild-type.